ATF6 is Required for ANP Secretion from the Heart
ATF6 is Required for ANP Secretion from the Heart
批准号:
10219762
负责人:
Chris Glembotski
金额:
$34.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-12-15 至 2022-11-30
关键词:
ATF6 geneAcuteAddressAdultAffectAntioxidantsAtrial Natriuretic FactorBiological ModelsBlood PressureBlood VolumeCalciumCardiacCardiac MyocytesCardiovascular PhysiologyCardiovascular systemCell NucleusCell membraneCellsCessation of lifeChronicCleaved cellCoupledCytoplasmic GranulesDataDevelopmentDockingElementsEnsureExcretory functionFoundationsGene DeletionGene ExpressionGenesGoalsGolgi ApparatusGrowth Factor ReceptorsHeartHeart AtriumHeart failureHormone secretionHormonesHypertensionIon ChannelIschemiaLinkMammalian CellMissionModelingMorbidity - disease rateMusMuscle CellsOrganOxidative StressPathologicPathway interactionsPlasmaPlayProteinsPublic HealthQuality ControlResearchRoleRough endoplasmic reticulumRouteSNAP receptorSNAP23 geneSecretory VesiclesSiteStretchingTimeTissuesTransgenic MiceUnited States National Institutes of HealthVasodilationVentricularbasecardiovascular effectscell typedesigndietaryendoplasmic reticulum stressgain of functionhemodynamicsin vivoinnovationloss of functionmisfolded proteinmortalitymouse modelnovelnovel strategiesnovel therapeuticspeptide hormonepressureprogramsprotein foldingprotein functionprotein misfoldingsalt sensitive hypertensionsmall moleculetranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
ER protein misfolding is sensed in the rough ER by ATF6, which is expressed in all mammalian cells. We
previously showed that in ventricular myocytes, in vivo, ischemia causes ER protein misfolding, which is
sensed by ATF6, converting it to a transcription factor that induces antioxidant genes that were not known to
be ATF6-regulated in any cell type. Our objective here is to study a new role for ATF6 as a critical element in
regulated secretion, focusing on atrial natriuretic peptide (ANP), a peptide hormone made in the ER of atrial
myocytes. Neither the function of ATF6 in the atria, nor its role in regulated hormone secretion has been
studied. Therefore, this proposal addresses a novel role for ATF6 as a linchpin in regulated hormone secretion
using a cardiac model system that we call the ATF6-ANP axis. Our preliminary data showed that under non-
stressed conditions, in contrast to ventricular cell and tissue, activated ATF6 was found in atrial cell and tissue,
even in the absence of ER stress. While activated ATF6 did not increase ANP gene expression in the atria, it
was required for ANP secretion from atrial myocytes. Mechanistically, we found that ATF6 induced several
secretory pathway proteins that were not previously known to be ATF6-regulated and have not been studied in
the heart, including the SNARE protein, SNAP23. SNAP23 is known to enhance granule docking and secretion
in other cell types. Based on this background and preliminary data, our hypothesis is that ATF6 is essential
for the secretion and beneficial cardiovascular (CV) effects of ANP. SNAP23 is a mechanistic link between
ATF6 and regulated ANP secretion. We will address this hypothesis in three specific aims, which are to: 1-
examine the effects of AAV9- and small molecule-based ATF6 gain-of-function, and conditional ATF6 gene
deletion maneuvers on ANP secretion from atrial myocytes and mouse hearts, 2-determine how ATF6 gain-
and loss-of-function affects plasma ANP and hemodynamic parameters in mouse models of dietary high-salt-
induced hypertension and pressure overload-induced heart failure, and 3-define the mechanistic role of the
ATF6-inducible secretory granule docking protein, SNAP23, in ANP secretion from cultured atrial myocytes
and mouse hearts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
-
批准号:10544178
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2022
-
负责人:Chris Glembotski
-
依托单位:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
-
批准号:10363838
-
项目类别:
-
资助金额:$61.5万
-
财政年份:2022
-
负责人:Chris Glembotski
-
依托单位:
Non-canonical ERAD as a Regulator of Cardiac Hypertrophy
-
批准号:10817347
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2022
-
负责人:Chris Glembotski
-
依托单位:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
-
批准号:10550149
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2020
-
负责人:Chris Glembotski
-
依托单位:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
-
批准号:10227351
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2020
-
负责人:Chris Glembotski
-
依托单位:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
-
批准号:10322459
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2020
-
负责人:Chris Glembotski
-
依托单位:
The ER Stress-Induced Selenoprotein, SelenoS, Regulates Proteostasis and Cardiac Hypertrophy
-
批准号:10218914
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2020
-
负责人:Chris Glembotski
-
依托单位:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
-
批准号:9389978
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2017
-
负责人:Chris Glembotski
-
依托单位:
Harnessing the Adaptive ER Stress Response in Myocardial Ischemia
-
批准号:9924642
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2017
-
负责人:Chris Glembotski
-
依托单位:
Role of the SR/ER E3 Ubiquitin Ligase Synoviolin 1 in Cardiac Hypertrophy
-
批准号:9102175
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2015
-
负责人:Chris Glembotski
-
依托单位:
Roles for SR/ER Protein Quantity and Quality Control in Cardiac Hypertrophy
-
批准号:8916213
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2014
-
负责人:Chris Glembotski
-
依托单位:
Development of a new system for the delivery of protective molecules to the heart
-
批准号:8079004
-
项目类别:
-
资助金额:$7.19万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Roles for ER Stress Inducible Cardiomyokines in the heart
-
批准号:8277336
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Development of a new system for the delivery of protective molecules to the heart
-
批准号:7877085
-
项目类别:
-
资助金额:$7.48万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Roles for ER Stress Inducible Cardiomyokines in the heart
-
批准号:7979118
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Roles for ER Stress Inducible Cardiomyokines in the heart
-
批准号:8488313
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Roles for ER Stress Inducible Cardiomyokines in the heart
-
批准号:8091434
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2010
-
负责人:Chris Glembotski
-
依托单位:
Surgery, Physiology and Immunohistopathology
-
批准号:7217647
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2006
-
负责人:Chris Glembotski
-
依托单位:
Restoration of Myocardial Healing Through Cardiokine Secretion
-
批准号:9100895
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2006
-
负责人:Chris Glembotski
-
依托单位:
Restoration of Myocardial Healing Through Cardiokine Secretion
-
批准号:8452819
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2006
-
负责人:Chris Glembotski
-
依托单位:
海外基金